Designed to expand to every demand, the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) offers proven procedural success and long-term outcomes through flexibility, strength and accuracy to treat aortoiliac occlusive disease.

    Expands to every demand

    Aortoiliac occlusive disease


    Contralateral access


    Calcified iliac stent delivery

    100% restoration of lumen diameter
    100% maintenance of stent length
    • 100% delivery to target lesion with no device dislodgement2
    • 100% stent retention2
    • 100% deployment at the target site2
    • 234 devices delivered
      • 50% bilateral treatment
      • 42% kissing stents
      • 32% TASC II C & D including occlusions
      • 18% contralateral deliveries
      • Predilatation not required
    100% stent delivery
    91.2% primary patency
    1. Panneton JM, Bismuth J, Gray BH, Holden A. Three-year follow-up of patients with iliac occlusive disease treated with the Viabahn Balloon-Expandable Endoprosthesis. Journal of Endovascular Therapy 2020;27(5):728-736.
    2. Bismuth J, Gray BH, Holden A, Metzger C, Panneton J; VBX FLEX Study Investigators. Pivotal study of a next-generation balloon-expandable stent-graft for treatment of iliac occlusive disease.  Journal of Endovascular Therapy 2017;24(5):629-637.
    3. Holden A, Takele E, Hill A, et al. Long-term follow-up of subjects with aortoiliac occlusive disease treated with the VIABAHN VBX balloon expandable endoprosthesis. Presented at Cardiovascular & Interventional Radiological Society of Europe (CIRSE) 2022; September 10-14, 2022; Barcelona, Spain. CardioVascular & Interventional Radiology 2022;45:Supplement:S147. Abstract 301.1.